ReviewFrontiers in pharmacology2026

Metabolic reprogramming in chronic kidney disease-cardiovascular disease comorbidity: from molecular mechanisms to therapeutic strategies.

Xiang-Jing Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.